We’re Committed to Eradicating T1D

Five million people are expected to have T1D by 2050 and 40,000 are diagnosed with T1D each year in the U.S. Our Executive Director Karen Hooper discussed DRC’s unique mission in raising research dollars for early-career scientists to develop innovative studies that will lead to the end of T1D. Learn about our commitment to not rest until T1D is eliminated in this recent Spotlight on the Community podcast.

Related News

Genetics in T1D

DRC’s Take on, “The type 1 diabetes gene TYK2 regulates βcell development and its responses to interferon-α”

Learn More +

DRC Is Excited to Share This Breaking T1D News Announced Yesterday by the FDA

Learn More +

November 2022 Newsletter

Learn More +